Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Navid Sobhani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1381-0283; OpenAlex author ID A5010923347. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. CDK8 remodels the tumor microenvironment and promotes resistance to KRAS G12D inhibitors and daraxonrasib in PDAC. Co-author DOI 10.1038/s44318-026-00854-5↗
  2. Recent Anti-KRAS G12D Therapies: A "Possible Impossibility" for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17040704↗
  3. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma. First author DOI 10.1371/journal.pone.0219566↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alberto D’Angelo · 2 shared papers, 2019–2025 · strength 0.46
  2. Giovanni Marchegiani · 1 shared paper, 2025 · strength 0.37
  3. Kathleen M. McAndrews · 1 shared paper, 2026 · strength 0.20
  4. Timothy Paul Heffernan · 1 shared paper, 2026 · strength 0.20
  5. Aislyn P. Schalck · 1 shared paper, 2026 · strength 0.20
  6. Krishnan K. Mahadevan · 1 shared paper, 2026 · strength 0.20
  7. Paola A. Guerrero · 1 shared paper, 2026 · strength 0.20
  8. Vincent Bernard · 1 shared paper, 2026 · strength 0.20
  9. Raghu Kalluri · 1 shared paper, 2026 · strength 0.20
  10. Anirban Maitra · 1 shared paper, 2026 · strength 0.20
  11. Giandomenico Roviello · 1 shared paper, 2019 · strength 0.09
  12. Stefan Bagby · 1 shared paper, 2019 · strength 0.09
  13. Daniele Generali · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.